Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BCL2L12
REST API REST API
Homo sapiens
BCL2L12 is differentially expressed in 135 experiments: 70 organism parts: accumbens, bone marrow, ... (68 more);, 52 disease states: normal, adrenocortical adenoma, ... (50 more);, 46 cell types 211 cell lines 14 compound treatments and 46 other conditions.
Orthologs A6QPJ9_BOVIN (Bos taurus)   Bcl2l12 (Mus musculus)   Bcl2l12 (Rattus norvegicus)   BCL2L12 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term apoptosis
UniProt Accession Q9HB09, Q3SY13
Search EB-eye ENSG00000126453
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-6573, E-GEOD-18105, E-MTAB-69, ... (10 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-24147, E-MEXP-903, E-MTAB-37, ... (16 experiments)

Factor Value U/D Experiments
HL-60
2
E-GEOD-24147, E-MTAB-37
A549
2
E-GEOD-3202, E-GEOD-6013
HT1080
2
E-MTAB-37, E-GEOD-20089
K562
2
E-MTAB-37, E-GEOD-24147
MCF-7
2
E-GEOD-5823, E-GEOD-20081
BM1604
1
E-MTAB-37
205 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-19069, E-GEOD-20193, E-GEOD-20033, ... (19 experiments)

Factor Value U/D Experiments
centroblast
1
E-GEOD-15271
naive B cell
1
E-TABM-702
activated natural killer cell
1
E-TABM-702
cancer cell culture
1
E-GEOD-14990
neutrophil
1
E-GEOD-12662
naive T cell
1
E-GEOD-1460
40 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-22148, E-GEOD-16363, E-GEOD-13987, ... (27 experiments)

Factor Value U/D Experiments
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
glioblastoma
2
E-GEOD-4290, E-GEOD-4412
myeloid leukemia
1
E-MTAB-37
pancreatic carcinoma
1
E-MTAB-37
Severe
1
E-GEOD-22148
liver carcinoma
1
E-MTAB-37
46 more value(s).


Compound treatment

studied in E-MEXP-1601, E-GEOD-20719, E-MEXP-1230, E-TABM-127, E-MEXP-1958, ... (9 experiments)

Factor Value U/D Experiments
unknown
1
E-GEOD-7307
anti-CD3 antibody (clone:OKT3)
1
E-MEXP-1601
Cxcl12
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
TTA
1
E-MEXP-2590
lipopolysaccharide
1
E-MEXP-1958
8 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-4619, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033

Disease staging
studied in E-GEOD-3325, E-GEOD-21887

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-4922

Ethnic group
studied in E-GEOD-1643

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-1482, E-GEOD-17385, E-GEOD-20847, E-MTAB-108, E-MEXP-2340, ... (6 experiments)

Genotype
studied in E-GEOD-3494, E-TABM-868, E-TABM-601, E-MEXP-1838

Growth condition
studied in E-GEOD-7011, E-MEXP-2657, E-TABM-127, E-GEOD-20540, E-GEOD-20504, ... (7 experiments)

Histology
studied in E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1290, E-TABM-666, E-GEOD-6919, ... (14 experiments)

Infection
studied in E-GEOD-12108

Karyotype
studied in E-GEOD-7214

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-1657, E-GEOD-1460

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

RNAi
studied in E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-12710

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-22541, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-15799, E-GEOD-12198 ... (5 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-3494, E-GEOD-4922

Tumor size
studied in E-GEOD-3494

Processing time: 0.428 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM